CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer [Phase 2]
Summary
Phase 2 trial update of enzalutamide plus LY3023414 in metastatic prostate cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11